Application 208600
- Type
- ANDA
- Sponsor
- AMPHASTAR PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ENOXAPARIN SODIUM | ENOXAPARIN SODIUM | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 300MG/3ML (100MG/ML) | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0548-5608 | Enoxaparin Sodium | enoxaparin sodium | Amphastar Pharmaceuticals, Inc. | ANDA | Current |
| 0548-5608 | Enoxaparin Sodium | enoxaparin sodium | Amphastar Pharmaceuticals, Inc. | ANDA | Current |
| 0548-5608 | Enoxaparin Sodium | enoxaparin sodium | Amphastar Pharmaceuticals, Inc. | ANDA | Current |
| 0548-5608 | Enoxaparin Sodium | enoxaparin sodium | Amphastar Pharmaceuticals, Inc. | ANDA | Current |
| 68001-464 | Enoxaparin Sodium | enoxaparin sodium | BluePoint Laboratories | ANDA | Current |
| 68001-464 | Enoxaparin Sodium | enoxaparin sodium | BluePoint Laboratories | ANDA | Current |
| 68001-464 | Enoxaparin Sodium | enoxaparin sodium | BluePoint Laboratories | ANDA | Current |
| 68001-464 | Enoxaparin Sodium | enoxaparin sodium | BluePoint Laboratories | ANDA | Current |